Development of a personalized stem cell therapy for RDEB delivered by cell suspension
Prof Ganna (Anya) Bilousova is joining us to talk about the pre-clinical development of a personalized stem cell therapy for recessive dystrophic epidermolysis bullosa delivered via cell suspension.
When? Thursday 25th September 2025, 2pm BST
Where? Online – register now
Who? This free webinar is open to all – EB patients and families, researchers, clinicians, and anyone with an interest in EB.
Please note that this is a live event only – a recording won’t be shared after the event.
Hosted by Sharmila Collins, founder of Cure EB, this is a free event open to all, but you must register.
There will be an opportunity to ask questions, but you can also submit questions in advance here
Dr. Ganna (Anya) Bilousova (Ph.D.) is an Associate Professor of Dermatology at the University of Colorado Anschutz Medical Campus (UCAMC), USA. She received her Bachelor of Science (B.S.) degree in Human Physiology in 2001 at Donetsk National University, Ukraine, and her Doctor’s degree (Ph.D.) in Biochemistry in 2007 at the University of Colorado, USA. Research in her laboratory is focused on studying skin and connective tissue diseases, such as Epidermolysis Bullosa and Ehlers-Danlos Syndrome and developing therapeutic approaches for these conditions. Dr. Bilousova also directs the Stem Cell Biobank and Disease Modeling Core at the University of Colorado and oversees the generation and genetic engineering of induced pluripotent stem cells (iPSCs) for the research community. Dr. Bilousova collaborates with Dr. Dennis Roop (Ph.D., Professor of Dermatology, UCAMC), Dr. Igor Kogut (Ph.D., Associate Professor of Dermatology , UCAMC) and Dr. Anna Bruckner (MD, Professor of Dermatology, UCAMC) in developing an iPSC-based therapy for skin diseases.